Exercise and Nutrition for Head and Neck Cancer Patients (ENHANCE)
2016年10月24日 更新者：Dr. Nicole Culos-Reed、University of Calgary
Exercise and Nutrition for Head and Neck Cancer Patients: A Patient Oriented, Clinic-Supported Randomized Controlled Trial
Research on physical activity and nutrition interventions aimed at positively impacting symptom management, treatment-related recovery and quality of life has largely excluded head and neck cancer populations.
This translates into a lack of clinical programming available for these patient populations.
Head and neck cancer patients deal with severe weight loss, with upwards of 70% attributed to lean muscle wasting, leading to extended recovery times, decreased quality of life (QoL), and impaired physical functioning.
To date, interventions to address body composition issues have focused solely on diet, despite findings that nutritional therapy alone is insufficient to mitigate changes.
A combined physical activity and nutrition intervention, that also incorporates important educational components known to positively impact behaviour change, is warranted for this population.
Pilot work suggests that there is large patient demand and clinic support from the health care professionals for a comprehensive program.
Therefore, the purpose of the present study is to examine the impact of timing of a 12-week PA and nutrition intervention (either during or following treatment) for HN cancer patients on body composition, recovery, serum inflammatory markers and quality of life.
In addition, the investigators will examine the impact of a 12-week maintenance program, delivered immediately following the intervention, on adherence, patient-reported outcomes (i.e., management of both physical and psychosocial treatment-related symptoms and side-effects), as well as return to work.
The investigators hypothesize that (1) patients who are randomized to the intervention at treatment start will experience improved symptom management and decreased lean body composition changes, directly improving recovery and QoL; (2) patients who receive a maintenance support program will have better long-term adherence and therefore superior treatment-related symptom management, physical and psychosocial functioning; and (3) return to work indices will improve and healthcare utilization costs will be lower in the participants who receive the immediate intervention (vs.
delayed) as well as in those who receive the maintenance program (vs.
no maintenance).
This research will facilitate advancements in patient wellness, survivorship, and autonomy, and carve the path for a physical activity and wellness education model that can be implemented in other cancer centers.
調査の概要
研究の種類
介入
入学 (実際)
60
段階
- 適用できない
連絡先と場所
このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。
研究場所
-
-
Alberta
-
Calgary、Alberta、カナダ、T2N4N2
- Tom Baker Cancer Centre
-
Calgary、Alberta、カナダ、T2N1N4
- University Of Calgary
-
-
参加基準
研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。
適格基準
就学可能な年齢
18年歳以上 (大人、高齢者)
健康ボランティアの受け入れ
いいえ
受講資格のある性別
全て
説明
Inclusion Criteria:
- Over 18 Years of Age
- Has received a diagnosis of nasopharyngeal, oropharyngeal or hypopharyngeal cancer
- Will receive radiation as part of treatment plan
- Able to walk without assistance
- Received clearance for exercise from treating oncologist
- Lives in Calgary, Alberta area
- Can speak and write English
- Is interested in participating in the study
研究計画
このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。
研究はどのように設計されていますか？
デザインの詳細
- 主な目的：支持療法
- 割り当て：ランダム化
- 介入モデル：並列代入
- マスキング：独身
武器と介入
参加者グループ / アーム |
介入・治療 |
|---|---|
|
実験的：Immediate Lifestyle Intervention - Maintenance Program
Patients will receive a 12-week lifestyle program during treatment.
Patients will also receive maintenance support following the 12-week program.
|
Participants in the Lifestyle Intervention will receive a 12-week individualized exercise and dietary program based on their exercise assessment and dual energy x-ray absorptiometry (DXA) scan results, will attend twice weekly group exercise classes, and perform their individualized at-home program an additional two times per week.
In addition, participants will be required to attend six education sessions during the 12-week intervention.
Patients randomized to receive the Maintenance Program Intervention following treatment will receive a Survivorship Care Plan outlining their physical activity, dietary, and health behaviour progress throughout the program, future goals, individualized maintenance strategies, and optional drop-in exercise sessions.
|
|
実験的：Immediate Lifestyle Intervention - No Maintenance Program
Patients will begin the 12-week lifestyle intervention during treatment.
Patients will not receive a maintenance support following the 12-week intervention.
|
Participants in the Lifestyle Intervention will receive a 12-week individualized exercise and dietary program based on their exercise assessment and dual energy x-ray absorptiometry (DXA) scan results, will attend twice weekly group exercise classes, and perform their individualized at-home program an additional two times per week.
In addition, participants will be required to attend six education sessions during the 12-week intervention.
|
|
実験的：Delayed Lifestyle Intervention - Maintenance Program
Patients will receive a 12-week lifestyle intervention program following treatment (12 weeks after diagnosis).
Patients will then receive maintenance support following the 12-week program.
|
Participants in the Lifestyle Intervention will receive a 12-week individualized exercise and dietary program based on their exercise assessment and dual energy x-ray absorptiometry (DXA) scan results, will attend twice weekly group exercise classes, and perform their individualized at-home program an additional two times per week.
In addition, participants will be required to attend six education sessions during the 12-week intervention.
Patients randomized to receive the Maintenance Program Intervention following treatment will receive a Survivorship Care Plan outlining their physical activity, dietary, and health behaviour progress throughout the program, future goals, individualized maintenance strategies, and optional drop-in exercise sessions.
|
|
実験的：Delayed Lifestyle Intervention - No Maintenance Program
Patients will receive a 12-week lifestyle intervention program following treatment completion (12 weeks following diagnosis).
Patients will not receive maintenance support following the 12-week program.
|
Participants in the Lifestyle Intervention will receive a 12-week individualized exercise and dietary program based on their exercise assessment and dual energy x-ray absorptiometry (DXA) scan results, will attend twice weekly group exercise classes, and perform their individualized at-home program an additional two times per week.
In addition, participants will be required to attend six education sessions during the 12-week intervention.
|
この研究は何を測定していますか？
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Change from Baseline in Body Composition
時間枠：At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
DXA Scan will be used to assess body composition
|
At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
二次結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Quality of Life
時間枠：At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
Quality of Life will be assessed using the Functional Assessment of Cancer Therapy- Anemia module (FACT-AN), and the NCCN-FACT Fact Head/Neck Symptom Index-22 (FHNSI-22).
|
At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
|
Physical Activity Behaviour
時間枠：At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
Physical activity will be assessed using Godin's (Godin, 1985) leisure score index (LSI) of the GLTEQ (Godin Leisure Time Exercise Questionnaire).
|
At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
|
Smoking History
時間枠：At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
Smoking history will be assessed by a self report questionnaire which will classify patients as non-smokers, former smokers and current smokers.
|
At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
|
Depression
時間枠：At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
Depression will be assessed using the Center for Epidemiological Studies on Depression Scale (CES-D).
|
At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
|
Karnofsky Performance Score (KPS)
時間枠：At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
The Karnofsky Performance Score (KSP) will be used to measure the participant's general ability to accomplish tasks of daily-living and overall well-being.
|
At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
|
Inflammatory Markers
時間枠：At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
Inflammatory factors will be evaluated as they are associated with cancer cachexia and muscle wasting and may be modified by exercise (Seruga et al., 2008; Baldwin, 2011).
An overnight fasted blood draw will be collected at baseline, 3 months post diagnosis, 6 months post diagnosis, 9 months post diagnosis, and 12 months post diagnosis.
Serum inflammatory cytokine concentrations will be assessed in-house (Dr.
Raylene Reimer's laboratory) according to our established protocols.
TNF, IL-6, IL-1, IL-8 and C-reactive protein will be quantified using Milliplex Human Cytokine kits (Millipore, Billerica, MA).
Plate reading will be provided as a fee-for service through Eve Technologies Inc. (Calgary, AB).
|
At baseline (diagnosis), and then at 3, 6, 9 and 12 months post diagnosis
|
|
Cancer related Symptom Management
時間枠：At baseline (diagnosis) and then 3, 6, 9, 12 months post diagnosis & every week before and after class during the 12 week intervention
|
Participants will complete the ESAS bi-weekly, before and after class.
The ESAS is a valid and reliable assessment tool to evaluate the nine more common symptoms experienced by cancer patients (Chang et al., 2000).
|
At baseline (diagnosis) and then 3, 6, 9, 12 months post diagnosis & every week before and after class during the 12 week intervention
|
|
Diet Behaviour - 3 Day food record
時間枠：At baseline (diagnosis) and 4 & 8 weeks, 3, 6, 9, 12 months post diagnosis.
|
The 3-Day Diet Record is said to be the most accurate for mean macronutrient content and appropriate for use in studies where subjects may consume a wide variety of foods (American Dietetics Association / Dietitians Canada, 2000).
Participants are instructed to record their daily consumption over a period of three days, one of which must be a weekend day.
Written instructions and a sample entry are provided to increase accuracy of the daily record.
|
At baseline (diagnosis) and 4 & 8 weeks, 3, 6, 9, 12 months post diagnosis.
|
|
Diet Behaviour: PG-SGA
時間枠：At baseline (diagnosis), each week during radiation treatment (6.5 weeks in duration), and 3, 6, 9, 12 months post diagnosis
|
The PG-SGA assessment tool has been show to improve treatment outcomes, decrease side-effects, and improve weight-management in cancer patients, and therefore will be used weekly to assess and identify malnutrition among patients (McMahon et al., 2000; Doyle et al., 2006).
|
At baseline (diagnosis), each week during radiation treatment (6.5 weeks in duration), and 3, 6, 9, 12 months post diagnosis
|
|
Health related Fitness Measures - Resting Heart Rate
時間枠：At baseline (diagnosis), and 3, 6, 9, 12 months post diagnosis.
|
Resting heart rate will be measured by palpating the radial artery and taking a 15 second count as per the CPAFLA protocol (CPAFLA, 2003).
|
At baseline (diagnosis), and 3, 6, 9, 12 months post diagnosis.
|
|
Health Related Fitness Outcome - Blood Pressure
時間枠：At baseline (diagnosis), and 3, 6, 9, 12 months post diagnosis.
|
A resting blood pressure (mmHg) will be measured in duplicate on the left arm using a sphygmomanometer and stethoscope using standardized procedures (CPAFLA, 2003).
|
At baseline (diagnosis), and 3, 6, 9, 12 months post diagnosis.
|
|
Health Related Fitness Outcome - 6 minute walk test
時間枠：At baseline (diagnosis), and 3, 6, 9, 12 months post diagnosis.
|
The six-minute walk test (6MWT) will be used to assess changes in functional aerobic capacity.
Using the standardized protocol, participants will be asked to walk as far as they can around a 400-meter track for six minutes [43].
The point reached at 6 minutes will be marked and measured to the nearest 0.5 meter.
Rating of perceived exertion (Borg scale) will be completed immediately after completion of the functional aerobic capacity test.
|
At baseline (diagnosis), and 3, 6, 9, 12 months post diagnosis.
|
|
Health Related Fitness Outcome - Grip Strength
時間枠：At baseline (diagnosis) and 3, 6, 9, and 12 months post diagnosis.
|
Muscular strength will be assessed using a combined grip strength of the right and left hands will also be assessed using a hand dynamometer.
A sum will be determined in kilograms from the best score of 2 trials recorded for each hand according to the CPAFLA protocol.
|
At baseline (diagnosis) and 3, 6, 9, and 12 months post diagnosis.
|
|
Health Related Fitness Outcome - Lower Body Strength
時間枠：At baseline (diagnosis), and 3, 6, 9, and 12 months post diagnosis
|
Lower body strength will be assessed using a 30-second sit to stand test.
The number of times participants can stand from a seated position in 30-second will be examined.
|
At baseline (diagnosis), and 3, 6, 9, and 12 months post diagnosis
|
|
Health Related Fitness Outcome - Flexibility
時間枠：At baseline (diagnosis) and 3, 6, 9, and 12 months post diagnosis
|
Flexibility will be assessed by a trunk forward flexion sit-and-reach test using a Wells-Dillon flexometer.
The test will follow a standard protocol, with two trials allowed and the highest score to the nearest 0.5 cm recorded.
|
At baseline (diagnosis) and 3, 6, 9, and 12 months post diagnosis
|
|
Health Related Fitness Outcome - Balance
時間枠：At baseline (diagnosis), and 3, 6, 9, and 12 months post diagnosis.
|
Balance will be assessed using a static balance test.
The test requires the participant to balance on one foot and then the other as long as they can (length of time to a maximum of 45 seconds) while standing on a 2.54 by 2.54 by 30.5 cm base using a standardized protocol, reported by Fleishman.
|
At baseline (diagnosis), and 3, 6, 9, and 12 months post diagnosis.
|
協力者と研究者
ここでは、この調査に関係する人々や組織を見つけることができます。
スポンサー
捜査官
- スタディディレクター：Lauren C Capozzi, PhD Student、University Of Calgary
- 主任研究者：Harold Lau, MD、Tom Baker Cancer Centre, University of Calgary
- 主任研究者：Raylene Reimer, PhD、University Of Calgary
出版物と役立つリンク
研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。
研究記録日
これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。
主要日程の研究
研究開始
2012年6月1日
一次修了 (実際)
2014年8月1日
研究の完了 (実際)
2014年12月1日
試験登録日
最初に提出
2012年8月31日
QC基準を満たした最初の提出物
2012年9月5日
最初の投稿 (見積もり)
2012年9月10日
学習記録の更新
投稿された最後の更新 (見積もり)
2016年10月26日
QC基準を満たした最後の更新が送信されました
2016年10月24日
最終確認日
2016年10月1日
詳しくは
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。